USJ Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Debt-Free Balance SheetA debt-free balance sheet and positive free cash flow provide resilience while profitability is pressured. This gives USANA flexibility to fund product development, support venture brands, and absorb operational volatility without relying heavily on external financing.
Product Innovation And Retail ExpansionNew products and broader retail distribution can diversify USANA beyond its traditional distributor model. Increasing physical availability supports consumer acquisition, improves channel reach, and may create more durable growth if launches achieve repeat purchasing.
Core Nutrition And China ResilienceStability in the core nutrition business provides an earnings foundation despite weakness in newer ventures. Improving momentum in Mainland China, supported by product launches and incentives, could strengthen a strategically important market over the medium term.
Bears Say
Severe Profitability ErosionOperating profitability has fallen sharply from historical levels despite a strong gross margin, showing that selling, marketing, and other operating costs are absorbing most product economics. Sustained margin compression reduces earnings quality and limits reinvestment capacity.
Declining Revenue And Customer BaseDeclining sales and customer counts indicate pressure on both USANA's established distributor network and its newer subscription business. A smaller active base can weaken repeat purchasing, reduce operating leverage, and make future growth dependent on costly customer acquisition.
Venture Brand Execution RisksHiya's weaker customer-acquisition economics and Rise's packaging failure expose execution risks in the venture portfolio. These issues have already reduced expected sales and margins, while the Hiya impairment signals that recovering prior growth assumptions may take time.
USANA Health News
USJ FAQ
What was USANA Health’s price range in the past 12 months?
Currently, no data Available
What is USANA Health’s market cap?
USANA Health’s market cap is CHF210.88M.
When is USANA Health’s upcoming earnings report date?
USANA Health’s upcoming earnings report date is Oct 27, 2026 which is in 58 days.
How were USANA Health’s earnings last quarter?
USANA Health released its earnings results on Aug 04, 2026. The company reported -CHF0.057 earnings per share for the quarter, missing the consensus estimate of CHF0.35 by -CHF0.407.
Is USANA Health overvalued?
According to Wall Street analysts USANA Health’s price is currently same.
Does USANA Health pay dividends?
USANA Health does not currently pay dividends.
What is USANA Health’s EPS estimate?
USANA Health’s EPS estimate is 0.09.
How many shares outstanding does USANA Health have?
Currently, no data Available
What happened to USANA Health’s price movement after its last earnings report?
USANA Health reported an EPS of -CHF0.057 in its last earnings report, missing expectations of CHF0.35. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of USANA Health?
Currently, no hedge funds are holding shares in CH:USJ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
USANA Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
CH:USJ Sentiment 67%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth CHF421.6K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.01%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-1.02%
Trailing 12-Months
Company Description
USANA Health
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
USJ Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call balanced clear strategic progress (strong balance sheet, stable core nutrition, successful new product launches, and retail expansion for Hiya and Rise) with meaningful near-term operational and financial headwinds (a $29M goodwill impairment for Hiya, a quarterly pre-tax loss with a $9M tax charge, lowered full-year outlook, Hiya DTC marketing pressures, and a Rise packaging disruption). Management emphasized long-term conviction and the ability to invest, but acknowledged near-term impacts to revenue, margins, and tax rates.View all CH:USJ earnings summariesHerbalife
―
Lifeway Foods
―
Nature's Sunshine Products
―
LifeVantage
―
FitLife Brands
―